Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Thomas

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|October 9, 1999
Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitutionM J Genin, T J Poel, P D May, et al.
Transplantation Proceedings|December 21, 2010
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimusL J W van der Laan, M Hudson, S McPherson, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships and increased metabolic stability of novel substituted pyridine analogsM J Genin, T J Poel, Y Yagi, et al.
Biochemical Pharmacology|March 22, 1996
The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, K C Chou, R J Lemay, et al.
Journal of Virology|June 1, 1996
(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypesR A Olmsted, D E Slade, L A Kopta, et al.
Global Change Biology|August 7, 2019
Zones of influence for soil organic matter dynamics: A conceptual framework for data and modelsClaudia Cagnarini, Eleanor Blyth, Bridget A Emmett, et al.
Journal of Medicinal Chemistry|September 28, 1998
Pyrimidine thioethers: a novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIVR A Nugent, S T Schlachter, M J Murphy, et al.
Journal of Medicinal Chemistry|September 13, 1996
Targeting delavirdine/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitorsD L Romero, R A Olmsted, T J Poel, et al.
Nature|December 4, 2009
Supernova 2007bi as a pair-instability explosionA Gal-Yam, P Mazzali, E O Ofek, et al.
Journal of Medicinal Chemistry|May 23, 1998
(-)-6-Chloro-2-[(1-furo[2, 3-c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorD G Wishka, D R Graber, L A Kopta, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|October 9, 1999
Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitutionM J Genin, T J Poel, P D May, et al.
Transplantation Proceedings|December 21, 2010
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimusL J W van der Laan, M Hudson, S McPherson, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships and increased metabolic stability of novel substituted pyridine analogsM J Genin, T J Poel, Y Yagi, et al.
Biochemical Pharmacology|March 22, 1996
The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptaseI W Althaus, K C Chou, R J Lemay, et al.
Journal of Virology|June 1, 1996
(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypesR A Olmsted, D E Slade, L A Kopta, et al.
Global Change Biology|August 7, 2019
Zones of influence for soil organic matter dynamics: A conceptual framework for data and modelsClaudia Cagnarini, Eleanor Blyth, Bridget A Emmett, et al.
Journal of Medicinal Chemistry|September 28, 1998
Pyrimidine thioethers: a novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIVR A Nugent, S T Schlachter, M J Murphy, et al.
Journal of Medicinal Chemistry|September 13, 1996
Targeting delavirdine/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitorsD L Romero, R A Olmsted, T J Poel, et al.
Nature|December 4, 2009
Supernova 2007bi as a pair-instability explosionA Gal-Yam, P Mazzali, E O Ofek, et al.
Journal of Medicinal Chemistry|May 23, 1998
(-)-6-Chloro-2-[(1-furo[2, 3-c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorD G Wishka, D R Graber, L A Kopta, et al.
Pageof 13